NEWYou can now listen to Fox News articles! On May 15, the U.S. Supreme Court will hear the argument in a series of cases that ask the court to decide whether individual district court judges…
-
-
President Donald Trump attended a breakfast with business leaders at the St. Regis Doha hotel in Qatar on Thursday morning where he remained firm that Tehran must choose between never having a nuclear weapon or…
-
When oil prices plunged to four-year lows this year, many analysts immediately turned to the inflation narrative, dusting off the long-held belief that where oil prices go, inflation follows. But this time, the correlation isn’t…
-
Brightstar Resources (BTR:AU) has announced May Production Update – Processing Underway Download the PDF here. This post appeared first on investingnews.com
-
Greenvale Energy (GRV:AU) has announced Multiple Uranium Anomalies Identified at Key NT Projects Download the PDF here. This post appeared first on investingnews.com
-
Investing
High Grade surface silver results up to 920g/t Ag recorded ~300m to the north and ~150m to the south of Elizabeth Hill mineralisation
Errawarra Resources Ltd (ASX: ERW) is pleased to advise that recent surface sampling at its Elizabeth Hill Project has returned multiple elevated portable XRF (pXRF) silver (Ag) readings including high grade results up to 920g/t…
-
(TheNewswire) VANCOUVER, BC, May 14, 2025 TheNewswire – Heritage Mining Ltd. (CSE: HML) (‘ Heritage ‘ or the ‘ Company ‘) is pleased to announce that, further to its news release dated May 7, 2025,…
-
Tolu Minerals Limited (“Tolu”) is pleased to announce the granting of its Ipi River tenement EL 2780 (Figure 1) covering 395.56 km2 of highly prospective copper-gold mineralisation. The historically discovered Ipi River porphyry deposit within…
-
Eric Nuttall, partner and senior portfolio manager at Ninepoint Partners, shares his outlook for oil and natural gas, honing in on supply, demand and prices. Global uncertainty has placed pressure on the oil market, and…
-
Investing
Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone
Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to announce important new data from our ongoing ACCENT clinical trial in pancreatic cancer. The trial is investigating the Company’s best-in-class FAK inhibitor narmafotinib…